In HNSCC, the expression of the macrophage polarity marker CXCL9-SPP1 (CS), but not M1 or M2 markers, is strongly negatively correlated with prognosis and can be used to identify protumor and antitumor pathways in the TME [6]. Here, CXCL9 is linked to head and neck squamous cell carcinoma.